Cramer Rosenthal McGlynn’s National Health Investors NHI Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-37,073	Closed	-$2.26M	–	225
2015 Q4	$2.26M	Sell	37,073 -14,327	-28%	-$854K	0.03%	183
2015 Q3	$2.96M	Hold	51,400	–	–	0.04%	184
2015 Q2	$3.2M	Hold	51,400	–	–	0.04%	182
2015 Q1	$3.65M	Buy	51,400 +1,400	+3%	+$101K	0.04%	181
2014 Q4	$3.5M	Buy	+50,000	New	+$3.25M	0.04%	175

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cramer Rosenthal McGlynn's NHI Position: Q1 2016 in Review

Cramer Rosenthal McGlynn sold out of National Health Investors (NHI) in Q1 2016, closing a stake of 37,073 shares — an estimated $2.26M sold.

Cramer Rosenthal McGlynn first reported a position in NHI in Q4 2014 and held it in 5 quarters. The position peaked at $3.65M in Q1 2015. 200 funds tracked by Wall St. Rank hold NHI as of Q1 2016.

Cramer Rosenthal McGlynn reported no remaining National Health Investors position as of Q1 2016 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 37,073 National Health Investors shares in Q1 2016, an estimated $2.26M.
Cramer Rosenthal McGlynn first reported a position in National Health Investors in Q4 2014 and held it in 5 quarters.
Cramer Rosenthal McGlynn's National Health Investors position peaked at $3.65M in Q1 2015.
200 funds tracked by Wall St. Rank held National Health Investors as of Q1 2016.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2016, filed 16 May 2016.